A better understanding of the biology of tuberculosis (TB) infection and improved drug combinations for the disease are two areas of research in which the TB Drug Accelerator (TBDA) has made strides since its inception a decade ago, according to a commentary whose authors include three Weill Cornell Medicine investigators and an investigator at Cornell University’s Ithaca campus who participate in the collaborative network.

Weill Cornell Medicine’s Office of Diversity and Inclusion has been recognized as a Diversity Champion by Crain’s New York Business as part of its first annual Excellence in Diversity and Inclusion Awards, announced July 15.

The genetic changes that underlie an especially lethal type of prostate cancer have been revealed in a new study by investigators at Weill Cornell Medicine. Learning more about what causes this type of cancer, called neuroendocrine prostate cancer (NEPC), could lead to new approaches for treating it.

SARS-CoV-2, the virus causing the global COVID-19 pandemic, can infect human pancreatic cells and alter their physiology, according to research from Weill Cornell Medicine and NewYork-Presbyterian investigators. Though the results come from analyses of autopsy samples and cultured cells and don't prove a direct causal relationship, they dovetail with clinical reports of glucose control problems in COVID-19 patients, suggesting a new dimension of disease development for a virus that has already killed millions.

The Weill Cornell Graduate School of Medical Sciences honored the students in the Class of 2021 for their academic achievements during a virtual convocation ceremony on May 19. Students and their families and friends watched a livestream of the event, as graduate school faculty announced the recipients of special awards and prizes.

Dr. Giovanni Manfredi, the Finbar and Marianne Kenny Professor in Clinical and Research Neurology at Weill Cornell Medicine’s Feil Family Brain and Mind Research Institute, has received an Outstanding Investigator Award (R35) from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS) to study the role of mitochondrial dysfunction in brain disease.